Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

VolitionRx Limited (VNRX)

4.88   -0.11 (-2.2%) 02-14 16:00
Open: 5 Pre. Close: 4.99
High: 5 Low: 4.83
Volume: 78,212 Market Cap: 196M
VolitionRX Ltd is a clinical-stage life sciences company. The company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.006 - 5.032 5.032 - 5.055
Low: 4.768 - 4.798 4.798 - 4.823
Close: 4.831 - 4.882 4.882 - 4.924

Technical analysis

as of: 2020-02-14 4:33:37 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 5.84     One year: 6.82
Support: Support1: 4.57    Support2: 4.31
Resistance: Resistance1: 5.00    Resistance2: 5.84
Pivot: 4.72
Moving Average: MA(5): 4.75     MA(20): 4.74
MA(100): 5.09     MA(250): 4.10
MACD: MACD(12,26): -0.02     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 78.20     %D(3): 64.08
RSI: RSI(14): 52.77
52-week: High: 6.84  Low: 2.65  Change(%): 70.6
Average Vol(K): 3-Month: 10125  10-Days: 10248

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
VNRX has closed below upper band by 24.2%. Bollinger Bands are 42.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to VNRX's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

VolitionRX (NYSEAMERICAN:VNRX) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
VolitionRX (NYSEAMERICAN:VNRX) posted its quarterly earnings data on Tuesday. The medical research company reported ($0.10) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.11) by $0.01, Fidelity Earnings reports. The business had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $0.06 million. Shares of NYSEAMERICAN VNRX traded up […]

The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) Acasti Pharma Inc (NASDAQ: ACST ) Cardiovascular Systems Inc (NASDAQ: CSII ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Masimo Corporation (NASDAQ: MASI ) VolitionRX Ltd (NYSE: VNRX ) Edwards Lifesciences Corp (NYSE: EW )(reported a beat-and-raise second quarter) Haemonetics Corporation (NYSE: HAE ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 24) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) GENFIT S A/ADR (NASDAQ: GNFT ) ContraVir Pharmaceuticals Inc (NASDAQ: HEPA) Innoviva Inc (NASDAQ: INVA ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Pluristem Therapeutics Inc. (NASDAQ: PSTI )(announced 1-for-10 reverse stock split) Regulus Therapeutics Inc (NASDAQ: RGLS )(FDA imposed partial clinical hold on its kidney disease drug) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Wave Life Sciences Ltd (NASDAQ: WVE ) Stocks In Focus FDA Approves Lilly's Nasally-Administered Low Blood Sugar Drug Eli Lilly And Co (NYSE: LLY ) said the FDA has approved its Baqsimi, the first and only nasally administered glucagon to treat severe hypoglycemia in a single, fixed, 3mg dose.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 41.09
Shares Float (M) 18.93
% Held by Insiders 44.52
% Held by Institutions 7.84
Shares Short (K) 417
Shares Short P. Month (K)

Stock Financials

EPS -0.446
Book Value (p.s.) 0.430
PEG Ratio
Profit Margin
Operating Margin -96941.63
Return on Assets (ttm) -46.6
Return on Equity (ttm) -102.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.386
Qtrly Earnings Growth
Operating Cash Flow (M) -13.77
Levered Free Cash Flow (M) -8.05

Stock Valuations

P/E -10.94
P/E Growth Ratio -0.02
P/BV 11.35
P/CF -14.56

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.